<DOC>
	<DOCNO>NCT01404442</DOCNO>
	<brief_summary>Objective : To compare analgesic effect intrathecal midazolam ketamine additive bupivacaine patient undergoing cesarean section . Methods : Following Ethics Committee approval inform patient consent , Ninety patient 18-45 yr old ASA physical status I II , schedule cesarean section spinal anesthesia , study prospective , double-blinded , randomized way . The patient randomly allocate one three group 30 . The ketamine group ( groupK ) receive bupivacaine 10mg combine 0.1 mg/kg ketamine preservative free , midazolam group ( group M ) receive bupivacaine 10mg combine with0.02 mg/ kg midazolam placebo group ( group P ) receive bupivacaine 10mg combine 0.5ml distilled water intrathecally . Time first requirement analgesic supplement , Sensory block onset time , maximum sensory level , onset motor block , duration blockade , hemodynamics variable , incidence hypotension , ephedrine requirement , bradycardia , hypoxemia [ Saturation peripheral oxygen ( SpO2 ) &lt; 90 ] , postoperative analgesic requirement Adverse event , sedation , dizziness , Pruritus postoperative nausea vomiting record . Patients instruct preoperatively use verbal rating scale ( VRS ) 0 10 ( 0no pain , 10maximum imaginable pain ) pain assessment . If VRS exceed four patient request supplement analgesic , diclofenac Na supp 100 mg give post-operative pain relief need . For breakthrough pain ( VRS &gt; 4 ) time administration diclofenac Na less 8h , Pethidine 25 mg IV give .</brief_summary>
	<brief_title>Evaluation Analgesic Effect Midazolam Ketamine Additive Intrathecal Bupivacaine Patients Undergoing Cesarean Section</brief_title>
	<detailed_description>The patient randomly allocate one three group 30 . The ketamine group ( groupK ) receive bupivacaine 10mg combine 0.1 mg/kg ketamine preservative free , midazolam group ( group M ) receive bupivacaine 10mg combine with0.02 mg/ kg midazolam placebo group ( group P ) receive bupivacaine 10mg combine 0.5ml distilled water intrathecally .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>patient American Society Anesthesiologists ( ASA ) physical status I II , undergo elective cesarean section significant coexist disease hepatorenal cardiovascular disease contraindication regional anesthesia local infection bleed disorder allergy ketamine midazolam longterm opioid use history chronic pain .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>midazolam</keyword>
	<keyword>ketamine</keyword>
	<keyword>intrathecal</keyword>
	<keyword>pain</keyword>
</DOC>